Search

Your search keyword '"Sphingosine kinase"' showing total 32 results

Search Constraints

Start Over You searched for: Descriptor "Sphingosine kinase" Remove constraint Descriptor: "Sphingosine kinase" Publication Type Magazines Remove constraint Publication Type: Magazines
32 results on '"Sphingosine kinase"'

Search Results

1. Investigators from Punjab Engineering College Report New Data on Cancer Research (in Silico studies, Synthesis and Biological Evaluation of 4,5-dehydrospisulosine Butyrate Ceramides As Potential Anticancer Agents).

2. Findings from McGovern Medical School University of Texas Provides New Data about Ubiquitins (Sphingosine Kinase 2 Regulates Protein Ubiquitination Networks In Neurons).

3. New Findings from Department of Statistics in the Area of Apoptosis Described (Elucidation of Mode of Anticancerous Activity of Metal Guanidinobenzimidazoles: a Computational and Experimental Screening).

4. Research on Lung Cancer Discussed by Researchers at Aligarh Muslim University (Thymoquinone, artemisinin, and thymol attenuate proliferation of lung cancer cells as Sphingosine kinase 1 inhibitors).

5. Measles virus co-opts epithelial-to-mesenchymal transition and live cell extrusion to exit human airway epithelia (Updated July 15, 2024).

6. Laboratory of Integrative Physiology in Veterinary Sciences Researcher Releases New Data on Amyloid (Inhibition of Sphingosine Kinase 1 Reduces Sphingosine-1-Phosphate and Exacerbates Amyloid-Beta-Induced Neuronal Cell Death in Mixed-Glial-Cell...).

7. Studies from Jena University Hospital in the Area of Hemolytic Uremic Syndrome Described (Deletion of Sphingosine Kinase 2 Attenuates Acute Kidney Injury in Mice with Hemolytic-Uremic Syndrome).

8. Sphingosine kinase 1 is integral for elastin deficiency-induced arterial hypermuscularization.

9. Study Results from Universite Paris Cite Provide New Insights into Biology (Role of Sphingosine Kinase 1 in Glucolipotoxicity-Induced Early Activation of Autophagy in INS-1 Pancreatic b Cells).

10. New Life Science Study Findings Have Been Reported by Investigators at National University of San Luis (Second Generation of Pyrimidin-quinolone Hybrids Obtained From Virtual Screening Acting As Sphingosine Kinase 1 Inhibitors and Potential...).

11. New Cancer Findings from University of Sao Paulo Described (The Accumulation of Sphingosine Kinase 2 Disrupts the Dna Damage Response and Promotes Resistance To Genotoxic Agents).

12. Studies in the Area of Cancer Gene Therapy Reported from University of South Australia (Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax).

13. Ministry of Education of China Details Findings in Osteoporosis (The Role of Sphk/s1p/s1pr Signaling Pathway In Bone Metabolism).

14. Study Data from University of Sao Paulo Update Understanding of Cancer (Accumulation of Sphingosine Kinase 2 Protein Induces Malignant Transformation In Oral Keratinocytes Associated With Stemness, Autophagy, Senescence, and Proliferation).

15. Sun Yat-sen University Researcher Publishes New Data on Hematopoietic Stem Cells (Loss of sphingosine kinase 2 promotes the expansion of hematopoietic stem cells by improving their metabolic fitness).

16. Researcher at University of Baghdad Publishes Research in Periodontitis (Assessment of the Salivary level of Sphingosine kinases-1 in periodontitis and its correlation with periodontal parameters).

17. Patent Issued for Inhibitor of sphingosine kinase 2 for treating Ebola (USPTO 11786541).

18. Data on Lymphoma Reported by Researchers at State University of New York (SUNY) Stony Brook (Targeting Sphingosine Kinase 1 In P53ko Thymic Lymphoma).

19. University of Florence Researcher Provides Details of New Studies and Findings in the Area of Adipokines (Adiponectin Modulates Smooth Muscle Cell Morpho-Functional Properties in Murine Gastric Fundus via Sphingosine Kinase 2 Activation).

20. Researchers at Johannes Gutenberg University Mainz Have Published New Study Findings on Glioblastomas (Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in...).

21. New Pain Study Findings Recently Were Reported by Researchers at Chongqing Medical University (Article a Novel Co-target of Acy1 Governing Plasma Membrane Translocation of Sphk1 Contributes To Inflammatory and Neuropathic Pain).

22. Investigators from University of Illinois Report New Data on Endocytosis (The Sphk1/s1p Axis Regulates Synaptic Vesicle Endocytosis Via Trpc5 Channels).

23. New Findings from Chosun University in the Area of Gastroenterology Reported (Integrative Roles of Sphingosine Kinase In Liver Pathophysiology).

24. University of Teramo Researchers Highlight Recent Research in Molecular Science (Sphingosine Kinases at the Intersection of Pro-Inflammatory LPS and Anti-Inflammatory Endocannabinoid Signaling in BV2 Mouse Microglia Cells).

25. New Biomarkers Data Have Been Reported by Researchers at University of Miami (Identification of Glomerular and Plasma Apolipoprotein M As Novel Biomarkers In Glomerular Disease).

26. Investigators from Qingdao University of Science and Technology Target Leukemia (Discovery and Design of Dual Inhibitors Targeting Sphk1 and Sirt1).

27. Study Findings on Chronic Lymphocytic Leukemia Reported by Researchers at Instituto de Medicina Experimental (Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia).

28. Findings from Central South University in Lung Cancer Reported (HOXC11 drives lung adenocarcinoma progression through transcriptional regulation of SPHK1).

29. Researchers' Work from University of Texas Southwestern Medical Center Focuses on Prostate Cancer (A Theranostic Small-Molecule Prodrug Conjugate for Neuroendocrine Prostate Cancer).

30. Data on Cancer Reported by Researchers at State University of New York (SUNY) Stony Brook (Upregulation of Sphingosine Kinase 1 In Response To Doxorubicin Generates an Angiogenic Response Via Stabilization of Snail).

31. Studies from Duke University Medical Center Further Understanding of Multiple Myeloma (Phase I Study of Opaganib, an Oral Sphingosine Kinase 2-specific Inhibitor, In Relapsed And/or Refractory Multiple Myeloma).

32. NIH grant supports development of a therapy that could stop the virus from spreading.

Catalog

Books, media, physical & digital resources